drugset / Trial / NCT02557087

Hyoscine ButylBromide for Intrapartum Analgesia

NCT02557087

Phase 2 Unknown 104 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to assess whether hyoscine butylbromide is as effective as pethidine for analgesia during the first stage of labor.

Timeline

Start
2015-09
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meperidine Unknown 50 mg Intravenous
Subject Scopolamine Unknown Intravenous

Indications

No indication recorded.